ASHUMGulf news and Dubai stocks, live

Interim Financial statements as of 30 June 2024 CHAE

Lunate S&P UAE UCITS ETF - Share A - ACCUMLATING Half-year results 47 pages

Document47 pages, text from the file; its scanned pages read by AshumOpen DFM’s file

Page 1

30/08/2024Mr. Hamed Ahmed AliCEODubai Financial Market (DFM)Dubai, United Arab Emirates

Greetings,

Subject: Notification by Lunate Capital Limited on behalf of Chimera UCITS ICAV

Please be informed that Lunate Capital Limited received the enclosed Condensed Interim Report & Unaudited Financial Statements from Chimera UCITS ICAV for the period 1st January 2024 to 30th June 2024.

Sincerely,

Sherif SalemHead of Public Markets

٢٠٢٤/٠٨/٣٠السيد / حامد أحمد علي المحترمالرئيس التنفيذيسوق دبي المالي (DFM)دبي، دولة الإمارات العربية المتحدة

تحية طيبة وبعد،

الموضوع: إخطار من شركة لونيت كابيتال ليمتد نيابة عن شيميرا يوسيتس ايكاف

نود اعلامكم بأن شركة لونيت كابيتال ليمتد استلمت تقرير البيانات المالية الموجزة المرحلية غير المدققة من شيميرا يوسيتس ايكاف للفترة من ١ يناير ٢٠٢٤ إلى ٣٠ يونيو ٢٠٢٤.

وتفضلوا بقبول وافر الاحترام،

شريف سالمرئيس قطاع الاستثمار - الأسواق المالية

LUNATE CAPITAL LIMITED12TH FLOOR, ALMARYAH TOWER,ABU DHABI,UNITED ARAB EMIRATESLUNATE.COM

Lunate Capital Limited is duly licensed and regulated by the ADGM Financial Services Regulatory Authority

Page 2

Chimera UCITS ICAVCondensed Interim Report & Unaudited Financial StatementsFor the financial period from 1 January 2024 to 30 June 2024ICAV Registration Number: C188915

Page 3

Chimera UCITS ICAVCondensed Interim Report & Unaudited Financial StatementsFor the financial period from 1 January 2024 to 30 June 2024Contents PageDirectors and Other Information 1Investment Manager’s Report 2Statement of Financial Position 6Statement of Comprehensive Income 8

Statement of Changes in Net Assets Attributable to Holders of Redeemable Participating Shares 10

Statement of Cash Flows 12Notes to the Unaudited Financial Statements 14Schedule of Investments 29Statement of Portfolio Changes 36

Appendix I: Securities Financing Transactions Regulation (“SFTR”) Disclosures 44

Page 4

Chimera UCITS ICAV

Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2024 to 30 June 2024 1

Directors and Other InformationDirectors of the ICAVFeargal Dempsey (Irish)1Seif Fikry (Egyptian)2Jason Loveless (British)2Syl O’Byrne (Irish)1Sherif Salem (Egyptian)2Registered Office of the ICAVArthur Cox BuildingTen Earlsfort TerraceDublin 2D02 T380IrelandManager

FundRock Management Company S.A.

33, rue de GasperichL-5826 HesperangeGrand-Duchy of Luxembourg

Investment Manager and Global Distributor Lunate Capital Limited

12th Floor, Al Maryah TowerAl Maryah IslandAbu DhabiUnited Arab EmiratesDepositary

The Bank of New York Mellon SA/NV, Dublin Branch Riverside II

Sir John Rogerson’s QuayGrand Canal DockDublin 2IrelandAdministrator, Registrar and Transfer AgentBNY Mellon Fund Services (Ireland)Designated Activity CompanyOne Dockland CentralGuild Street

International Financial Services Centre Dublin 1

IrelandSecretaryBradwell LimitedTen Earlsfort TerraceDublin 2D02 T380IrelandIndependent AuditorsDeloitte Ireland LLP29 Earlsfort TerraceDublin 2IrelandIrish Legal AdvisersArthur CoxTen Earlsfort TerraceDublin 2Ireland

1 Independent and Non-executive Director.

2 Non-executive Director.

Page 5

Chimera UCITS ICAV

Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2024 to 30 June 2024

2Investment Manager’s Report

The Chimera UCITS ICAV Fund ended the first half of 2024 with assets under management of AED 166.9 million. As of the end of June, there are four sub-funds under the Chimera UCITS ICAV Fund, of which one was launched in February 2021, one was launched in August 2023, and the last two were launched in 2024. The sub-funds are the Chimera S&P UAE UCITS ETF (“the First Sub-Fund”), the Chimera S&P Pakistan UCITS ETF (“the Second Sub-Fund”), the Chimera JP Morgan UAE Bond UCITS ETF (“the third Sub-Fund”), and the Chimera S&P Japan UCITS ETF (“the fourth Sub-Fund”).

Chimera S&P UAE UCITS ETF (“the First Sub-Fund”)

The Chimera S&P UAE UCITS ETF has two share classes launched on 23 February 2021, an accumulating share class listed on the Dubai Financial Market (DFM) and an income share class listed on the Abu Dhabi Securities Exchange (ADX). The dividends received by the fund’s income share class are intended to be distributed semi-annually when available. As of 30th June 2024, the DFM-listed Share Class A (Bloomberg code: CHAE) had a NAV of AED 4.646, and the ADX-listed Share Class D (Bloomberg code: CHAEIN) had a NAV of AED 4.152.

The return for the ETF for H1 2024 was -3.5% versus the S&P UAE BMI Liquid 20/35 Capped Index’s (the “Index”) return of - 3.0%. Since inception, the fund’s return is 26.6% versus the index’s 31.0% return.

During the second quarter of 2024, a dividend of AED 0.0976 was announced for the ADX-listed Share Class D, translating into a dividend yield of 2.4% based on the end of June NAV. The ex-dividend date was 14 June 2024, and the payment date is 10 July 2024.

* The Fund and Index data specified in the graph are calculated since the inception of the Fund

Tracking Difference & Tracking Error

The Fund's tracking difference in H1 2024 was -50.3 bps, of which 47.4 bps were management fees, resulting in a net tracking difference of -3.0 bps.

2021 2022 2023 H1 2024 ITD

ETF Return35.1%-4.8%2.0%-3.5%26.6%

Index Return36.4%-3.9%2.9%-3.0%31.0%

Tracking Diff (bps)-133.1-90.4-97.7-50.3-437.6

Total Expense Ratio(bps)

88.671.495.047.4328.5

Tracking Diff Net(bps)

-44.5-18.9-2.7-3.0-109.1

Annualized TrackingError (bps)

36.931.734.038.133.0

As stated under the Investment Policy of the Chimera S&P UAE UCITS ETF Supplement, it is expected, but not guaranteed, that the level of annual Tracking Difference (net of fees) shall not exceed 2% and the level of annualized Tracking Error shall not exceed 1%, in normal market conditions.

Page 6

Chimera UCITS ICAV

Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2024 to 30 June 2024 3

Investment Manager’s Report (continued)Assets Under Management

The Assets Under Management (AUM) of the Chimera S&P UAE UCITS ETF Fund as of 30 June 2024 was AED 118.6 million.

The AUM of Share Class D – Distributing (CHAEIN), listed on the Abu Dhabi Securities Exchange (ADX) were AED 116.3 million, while the AUM of Share Class – A – Accumulating (CHAE), listed on the Dubai Financial Market (DFM) were AED 2.3 million as of 30 June 2024.

During the first half, the ADX-listed share class (CHAEIN) traded AED 810.5 thousand. Meanwhile, the DFM-listed share class (CHAE) traded AED 28.4 thousand in the secondary market.

The S&P UAE BMI Liquid 20/35 Capped Index was rebalanced twice in the first half of 2024. Three additions and three deletions were made in the first quarter, and two additions and two deletions were made in the second quarter.

Chimera S&P Pakistan UCITS ETF (“the Second Sub-Fund”)

The Chimera S&P Pakistan UCITS ETF was launched on 17 August 2023. The fund replicates the S&P Pakistan BMI Liquid 20/35 Capped Index (Bloomberg code: SPPKRCAP), which tracks the performance of the 15 biggest and most liquid stocks listed on the Pakistan Stock Exchange. The fund has one share class – Share Class D Income (Bloomberg code: CHPKIN) – and dividends received by the fund are intended to be distributed semi-annually when available.

As of 30 June 2024, the fund’s NAV was AED 6.164. For the first half of 2024, the fund's return in PKR (the base currency) was 27.4% versus the S&P Pakistan BMI Liquid 20/35 Capped Index’s (the “Index”) return of 22.7%. Since inception, the fund’s return is 57.8% versus the index’s 46.6% return.

* The Fund and Index data specified in the graph are calculated since the inception of the Fund

Tracking Difference

The tracking difference for the Fund in H1 2024 was +467.8 bps, of which 48.7 bps is attributed to management fees, resulting in a net tracking difference of +516.5 bps. The primary cause of this variance is that the dividends received by the fund since inception have been reinvested. Since the index is a price return index, it does not account for dividends. Fund distribution is expected to be paid on 19 July 2024. For the same period, the annualized tracking error was 29.2 bps.

2023 1H2024 ITD

Fund Return*23.8%27.4%57.8%

Index Return*19.4%22.7%46.6%

Tracking Diff (bps)442.0467.81,121.9

Total Expense Ratio (bps)36.648.785.5

Tracking Diff net (bps)478.6516.51,207.5

Annualized Tracking Error (bps)32.329.230.5

*All returns are in base currency (PKR); Performance returns/figures previously reported in AED will now be reported in the base currency.

As stated under the Investment Policy of the Chimera S&P Pakistan UCITS ETF Supplement, it is expected, but not guaranteed, that the level of annual Tracking Difference (net of fees) shall not exceed 2% and the level of annualized Tracking Error shall not exceed 1%, in normal market conditions.

Page 7

Chimera UCITS ICAV

Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2024 to 30 June 2024 4

Investment Manager’s Report (continued)Assets Under Management

As of 30 June 2024, the Chimera S&P Pakistan UCITS ETF had Assets Under Management (AUM) of AED 6.2 million (PKR 467.1 million). During the first half of 2024, the ETF witnessed no primary activity. In the secondary market, the ETF traded for AED 133.5 thousand.

The S&P Pakistan BMI Liquid 20/35 Capped Index was rebalanced once in the first half of 2024 in June when it had one addition and one deletion.

Chimera JP Morgan UAE Bond UCITS ETF

The Chimera JP Morgan UAE Bond UCITS ETF was launched on 25 March 2024. The fund aims to replicate the performance of the J.P Morgan MECI UAE Investment Custom Index, which tracks the performance of liquid, USD-denominated investment-grade instruments from the United Arab Emirates (UAE). The fund has one share class – Share Class D Distributing (Bloomberg code: BONDAE) – and coupons received by the fund are intended to be distributed semi-annually when available.

The ETF ended the first half of 2024 with an NAV of AED 3.679. From inception to the end of June 2024, the fund's return in USD (the base currency) was 0.2% versus the J.P Morgan MECI UAE Investment Custom Index’s (the “Index”) return of 1.0%.

* The Fund and Index data specified in the graph are calculated since inception of the Fund

Tracking Difference & Tracking Error

From inception in March 2024 to the end of June 2024, BONDAE had a return of 0.2%, while the index returned 1.0% over the same period resulting in a tracking difference of 83.6bps. Net of the ETF’s total expense ratio, the net tracking difference was 70.5bps. For the same period, the annualized Tracking Error was 76.4bps.

ITDFund Return* 0.2%Index Return* 1.0%Tracking Diff (bps) -83.6Total Expense Ratio (bps) 13.1Tracking Diff net (bps) -70.5Annualized Tracking Error (bps) 76.4

*All returns are in base currency (USD); figures since inception on March 25th, 2024.

As stated under the Investment Policy of the Chimera JP Morgan UAE Bond UCITS ETF Supplement, it is expected, but not guaranteed, that the level of annual Tracking Difference (net of fees) shall not exceed 2% and the level of annualized Tracking Error shall not exceed 1%, in normal market conditions.

Assets Under Management

As of 30 June 2024, the Chimera JP Morgan UAE Bond UCITS ETF had Assets Under Management (AUM) of AED 22.1 million (USD 6.0 million). During the first half of 2024, the ETF witnessed a primary activity of AED 25.7 million. In the secondary market, the ETF traded AED 9.6 million.

The J.P Morgan MECI UAE Investment Custom Index is rebalanced monthly. There were five additions and three deletions in the April rebalance, three additions and one deletion in the May rebalance, and one addition and one deletion in June.

Page 8

Chimera UCITS ICAV

Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2024 to 30 June 2024 5

Investment Manager’s Report (continued)Chimera S&P Japan UCITS ETF (“the Fourth Sub-Fund”)

The Chimera S&P Japan UCITS ETF was launched on 28 May 2024. The fund replicates the S&P Japan BMI Liquid 35/20 Capped Index (Bloomberg code: SPJPLCAP), which tracks the performance of the 30 biggest and most liquid stocks listed on the Tokyo Stock Exchange. The fund has one share class – Share Class D Income (Bloomberg code: JPANI) – and dividends received by the fund are intended to be distributed semi-annually when available.

As of 30 June 2024, the fund’s NAV was AED 3.647. From inception to the end of June 2024, the fund's return in JPY (the base currency) was 1.8%, compared to the S&P Japan BMI Liquid 35/20 Capped Index’s (the “Index”) return of 1.8%.

* The Fund and Index data specified in the graph are calculated since the inception of the Fund

Tracking Difference

The Fund's tracking difference in H1 2024 was -6.0 bps, of which 8.7 bps is attributed to management fees, resulting in a net tracking difference of +2.7 bps.

ITDFund Return* 1.8%Index Return* 1.8%Tracking Diff (bps) -7.0Total Expense Ratio (bps) 8.7Tracking Diff net (bps) 1.7Annualized Tracking Error (bps) 36.2

*All returns are in base currency (JPY); figures since inception on May 28th, 2024.

As stated under the Investment Policy of the Chimera S&P Japan UCITS ETF Supplement, it is expected, but not guaranteed, that the annual Tracking Difference (net of fees) will not exceed 2% and the annualized Tracking Error will not exceed 1% in normal market conditions.

Assets Under Management

As of 30 June 2024, the Chimera S&P Japan UCITS ETF had Assets Under Management (AUM) of AED 20.1 million (JPY 878.7 million). During the first half of the year, there was total primary trading activity of AED 23.8 million. In the secondary market, the ETF traded for AED 4.8 million.

The S&P Japan BMI Liquid 35/20 Capped Index was rebalanced once in June, with one addition and one deletion.

Lunate Capital LimitedDate: July 2024

Page 9

Chimera UCITS ICAV

Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2024 to 30 June 2024 6

Statement of Financial PositionChimera S&PUAEUCITS ETFChimera S&PUAEUCITS ETFChimera S&PPakistanUCITS ETFChimera S&PPakistanUCITS ETF*As at30 June2024As at31 December2023As at30 June2024As at31 December2023Notes AED AED PKR PKRAssets

Cash and cash equivalents63,191,6352,520,77932,350,3282,747,144

Financial assets at fair value through profit or loss:

Transferable securities3118,445,857125,540,893435,828,711364,655,675

Total assets121,637,492128,061,672468,179,039367,402,819

Liabilities

Accrued Management fees10(315,612)(315,820)(1,126,277)(840,785)

Distributions Payable(2,732,800)(1,996,400)––

Total liabilities(3,048,412)(2,312,220)(1,126,277)(840,785)

Net assets attributable to holders of

redeemable participating shares14118,589,080125,749,452467,052,762366,562,034

Number of redeemable participating shares

Class A Accumulating Shares4500,000500,000––

Class D Distributing Shares428,000,00028,000,0001,000,0001,000,000

Net asset value per share attributable toholders of redeemable participatingshares

Class A Accumulating Shares144.6464.813––

Class D Distributing Shares144.1524.405467.053366.562

*Chimera S&P Pakistan UCITS ETF was launched on 17 August 2023.

The accompanying notes form an integral part of the unaudited financial statements.

Page 10

Chimera UCITS ICAV

Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2024 to 30 June 2024 7

Statement of Financial Position (continued)Chimera JP MorganUAE BondUCITS ETF**Chimera S&P JapanUCITS ETF***As at30 June2024As at30 June2024Notes USD JPYAssets

Cash and cash equivalents643,6833,250,422

Financial assets at fair value through profit or loss:

Transferable securities35,910,131876,166,465

Dividends receivable–24,172

Interest Income Receivable63,550–

Total assets6,017,364879,441,059

Liabilities

Accrued Management fees10(8,152)(786,320)

Total liabilities(8,152)(786,320)

Net assets attributable to holders of redeemable

participating shares146,009,212878,654,739

Number of redeemable participating shares

Class D Distributing Shares46,000,0005,500,000

Net asset value per share attributable to holders ofredeemable participating shares

Class D Distributing Shares141.002159.755

**Chimera JP Morgan UAE Bond UCITS ETF was launched on 25 March 2024. Therefore, there are no comparatives as at the financial year ended 31 December 2023.

***Chimera S&P Japan UCITS ETF was launched on 28 May 2024. Therefore, there are no comparatives as at the financial year ended 31 December 2023.

The accompanying notes form an integral part of the unaudited financial statements.

Page 11

Chimera UCITS ICAV

Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2024 to 30 June 2024 8

Statement of Comprehensive IncomeChimera S&P UAEUCITS ETFChimera S&P UAEUCITS ETFChimera S&PPakistanUCITS ETF*Financial Period1 January 2024to 30 June 2024Financial Period1 January 2023to 30 June 2023Financial Period1 January 2024to 30 June 2024AED AED PKRIncome

Interest income–––

Dividend income5,279,6673,957,81918,439,464

Net (losses)/gains on financial assets at fair value

through profit or loss5(9,093,077)(4,322,234)84,084,729

Total investment (expense)/income(3,813,410)(364,415)102,524,193

Operating expenses

Management fees8,10(614,162)(631,606)(2,033,465)

Total operating expenses(614,162)(631,606)(2,033,465)

Net (expense)/income(4,427,572)(996,021)100,490,728

Finance costsDistributions to holders of redeemable participating

shares16(2,732,800)(1,713,900)–

Interest expense–––

Total Finance costs(2,732,800)(1,713,900)–

(Loss)/profit for the period before tax(7,160,372)(2,709,921)100,490,728

(Decrease)/increase in net assets resulting fromoperations attributable to holders of redeemable

participating shares(7,160,372)(2,709,921)100,490,728

*Chimera S&P Pakistan UCITS ETF was launched on 17 August 2023. Therefore, there are no comparatives as at the financial period ended 30 June 2023.

Gains and losses arose solely from continuing investment activities. There were no gains or losses other than those dealt with in the Statement of Comprehensive Income.

The accompanying notes form an integral part of the unaudited financial statements.

Page 12

Chimera UCITS ICAV

Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2024 to 30 June 2024 9

Statement of Comprehensive Income (continued)Chimera JP MorganUAE BondUCITS ETF**Chimera S&P JapanUCITS ETF***Financial Period from25 March 2024to 30 June 2024Financial Period from28 May 2024to 30 June 2024USD JPYIncome

Interest income78,917–

Dividend income–24,172

Net (losses)/gains on financial assets at fair value through

profit or loss5(65,191)16,754,387

Other income84–

Total investment income13,81016,778,559

Operating expenses

Management fees8,10(8,152)(786,320)

Total operating expenses(8,152)(786,320)

Net income5,65815,992,239

Finance costs

Distributions to holders of redeemable participating shares16––

Interest expense(107)–

Total Finance costs(107)–

Profit for the period before tax5,55115,992,239

Increase in net assets resulting from operationsattributable to holders of redeemable participating

shares5,55115,992,239

**Chimera JP Morgan UAE Bond UCITS ETF was launched on 25 March 2024. Therefore, there are no comparatives as at the financial period ended 30 June 2023.

***Chimera S&P Japan UCITS ETF was launched on 28 May 2024. Therefore, there are no comparatives as at the financial period ended 30 June 2023.

Gains and losses arose solely from continuing investment activities. There were no gains or losses other than those dealt with in the Statement of Comprehensive Income.

The accompanying notes form an integral part of the unaudited financial statements.

Page 13

Chimera UCITS ICAV

Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2024 to 30 June 2024 10

Statement of Changes in Net Assets Attributable to Holders of Redeemable Participating Shares

Chimera S&P UAEUCITS ETFChimera S&P UAEUCITS ETFChimera S&PPakistanUCITS ETF*Financial Period1 January 2024to 30 June 2024Financial Period1 January 2023to 30 June 2023Financial Period1 January 2024to 30 June 2024AED AED PKRNet assets attributable to holders of redeemable

participating shares at beginning of the period125,749,452131,433,922366,562,034

(Decrease)/increase in net assets resulting from operations attributable to holders of redeemable

participating shares(7,160,372)(2,709,921)100,490,728

Issue of redeemable participating shares – – – Redemption of redeemable participating shares – – – Increase in net assets resulting from share

transactions–––

Net assets attributable to holders of redeemable

participating shares at end of the period118,589,080128,724,001467,052,762

*Chimera S&P Pakistan UCITS ETF was launched on 17 August 2023. Therefore, there are no comparatives as at the financial period ended 30 June 2023.

The accompanying notes form an integral part of the unaudited financial statements.

Page 14

Chimera UCITS ICAV

Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2024 to 30 June 2024 11

Statement of Changes in Net Assets Attributable to Holders of Redeemable Participating Shares (continued) Chimera JP Morgan

UAE BondUCITS ETF**Chimera S&P JapanUCITS ETF***Financial Period from25 March 2024to 30 June 2024Financial Period from28 May 2024to 30 June 2024USD JPYNet assets attributable to holders of redeemableparticipating shares at beginning of the period – –Increase in net assets resulting from operations attributable to

holders of redeemable participating shares5,55115,992,239

Issue of redeemable participating shares6,500,000942,000,000

Redemption of redeemable participating shares(496,339)(79,337,500)

Increase in net assets resulting from share transactions6,003,661862,662,500

Net assets attributable to holders of redeemable

participating shares at end of the period6,009,212878,654,739

**Chimera JP Morgan UAE Bond UCITS ETF was launched on 25 March 2024. Therefore, there are no comparatives as at the financial period ended 30 June 2023.

***Chimera S&P Japan UCITS ETF was launched on 28 May 2024. Therefore, there are no comparatives as at the financial period ended 30 June 2023.

The accompanying notes form an integral part of the unaudited financial statements.

Page 15

Chimera UCITS ICAV

Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2024 to 30 June 2024 12

Statement of Cash FlowsChimera S&P UAEUCITS ETFChimera S&P UAEUCITS ETFChimera S&PPakistanUCITS ETF*Financial Period1 January 2024to 30 June 2024Financial Period1 January 2023to 30 June 2023Financial Period1 January 2024to 30 June 2024AED AED PKRCash flows from operating activities

Proceeds from sale of investments9,395,2669,752,00456,999,909

Purchase of investments(11,393,308)(11,599,039)(44,088,216)

Interest income received – – –

Dividend income received5,279,6673,957,81918,439,464

Operating expenses paid(614,369)(666,870)(1,747,973)

Net cash inflow from operating activities2,667,2561,443,91429,603,184

Cash flows from financing activities Distributions paid to holders of redeemable

participating shares16(1,996,400)(2,143,100)–

Interest expense paid – – –Amounts received on issue of redeemable

participating shares–––

Amounts paid on redemption of redeemable

participating shares–––

Net cash outflow from financing activities(1,996,400)(2,143,100)–

Net increase/(decrease) in cash and cash

equivalents670,856(699,186)29,603,184

Cash and cash equivalents at beginning of period2,520,7793,091,7432,747,144

Cash and cash equivalents at end of the period63,191,6352,392,55732,350,328

*Chimera S&P Pakistan UCITS ETF was launched on 17 August 2023. Therefore, there are no comparatives as at the financial period ended 30 June 2023.

The accompanying notes form an integral part of the unaudited financial statements.

Page 16

Chimera UCITS ICAV

Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2024 to 30 June 2024 13

Statement of Cash Flows (continued)Chimera JP MorganUAE BondUCITS ETF**Chimera S&P JapanUCITS ETF***Financial Period from25 March 2024to 30 June 2024Financial Period from28 May 2024to 30 June 2024USD JPYCash flows from operating activities

Proceeds from sale of investments^1,027,20513,292,837

Purchase of investments^(6,992,299)(10,042,415)

Interest income received5,139–

Dividend income received – –

Other income received84–

Net cash (outflow)/inflow from operating activities(5,959,871)3,250,422

Cash flows from financing activitiesDistributions paid to holders of redeemable participating

shares16––

Interest expense paid(107)–

Amounts received on issue of redeemable participating

shares^6,500,000–

Amounts paid on redemption of redeemable participating

shares^(496,339)–

Net cash inflow from financing activities6,003,554–

Net increase in cash and cash equivalents43,6833,250,422

Cash and cash equivalents at beginning of period – –

Cash and cash equivalents at end of the period643,6833,250,422

**Chimera JP Morgan UAE Bond UCITS ETF was launched on 25 March 2024. Therefore, there are no comparatives as at the financial period ended 30 June 2023.

***Chimera S&P Japan UCITS ETF was launched on 28 May 2024. Therefore, there are no comparatives as at the financial period ended 30 June 2023.

^Chimera S&P Japan UCITS ETF engaged in in-kind subscriptions and redemptions of redeemable participating shares during the financial period amounting to JPY 942,000,000 and JPY 79,337,500, respectively (refer to Note 4 to the financial statements for further details). All the subscriptions into and redemptions out of the Sub-Fund for the financial period were achieved via in-kind contribution and withdrawal of assets of the same amount representing consideration for purchase and sale of investments.

The accompanying notes form an integral part of the unaudited financial statements.

Page 17

Chimera UCITS ICAVCondensed Interim Report & Unaudited Financial StatementsFor the financial period from 1 January 2024 to 30 June 2024Notes to the Unaudited Financial Statements (continued)14

1. Organisation

Chimera UCITS ICAV (the “ICAV”) is an Irish collective asset-management vehicle registered in Ireland pursuant to the Irish Collective Asset-Management Vehicles Act 2015 (the “ICAV Act”) on 21 January 2019 with registration number C188915 and was authorised by the Central Bank of Ireland (the “CBI”) on 18 November 2020 as an Undertaking for Collective Investment in Transferable Securities (“UCITS”) under the provisions of the European Communities (Undertakings for Collective Investment in Transferable Securities) Regulations 2011, (as amended) (the “UCITS Regulations”) and the Central Bank (Supervision and Enforcement) Act 2013 (Section 48(1)) (Undertakings for Collective Investment in Transferable Securities) Regulations 2019 (the "Central Bank UCITS Regulations").

The ICAV is structured as an umbrella fund with segregated liability between Funds (individually a “Sub-Fund” and collectively “Sub-Funds”). The Instrument of Incorporation provides that the ICAV may offer separate classes of shares, each representing interests in a Sub-Fund comprising a distinct portfolio of investments. In addition, each Sub-Fund may be further divided into a number of different classes within the Sub-Fund. With the prior approval of the CBI, the ICAV from time to time may create additional Sub-Funds. The creation of further share classes shall be notified to and prepared and submitted to the CBI in accordance with the CBI requirements.

As at 30 June 2024, the ICAV consisted of four Sub-Fund, Chimera S&P UAE UCITS ETF which was launched on 23 February 2021, Chimera S&P Pakistan UCITS ETF (the “Sub-Fund”) which was launched on 17 August 2023, Chimera JP Morgan UAE Bond UCITS ETF which was launched on 25 March 2024 and Chimera S&P Japan UCITS ETF which was launched on 28 May 2024.

The Sub-Funds seek to provide investors with a total return, taking into account capital and income returns, which reflects the returns of equity and bond indices called the S&P UAE BMI Liquid 20/35 Capped Index (the “Index”), the S&P Pakistan BMI Liquid 35/20 Capped Index (the "Index"), J.P. Morgan MECI UAE Investment Grade Custom Index (the "Index") and S&P Japan BMI Liquid 35/20 Capped Index (the "Index"), respectively.

The Index for Chimera S&P UAE UCITS ETF is a modified weighted total return index measuring the performance of 30 of the largest constituents of the S&P UAE BMI Index. The S&P UAE BMI Index is a leading benchmark for tracking performance of the UAE equity markets. The Index is comprised of the constituents of the S&P UAE BMI Index that meet the following eligibility requirements: (i) companies must have no more than ten non-trading days over the previous quarter; and (ii) have a three-month average daily value traded volume of at least US$ 500,000 for at least one of the two quarterly periods preceding the rebalancing reference date.

The Index for Chimera S&P UAE UCITS ETF applies a UCITS capping screen of 20/35. This is to allow the Fund, whose policy is to replicate the Index, to invest up to 20% of its net assets in individual securities with the 20% limit being raised up to 35% in the case of a single issuer were justified by exceptional market conditions which may include the dominance of a particular issuer in the relevant market. The Index provider, S&P, has set triggers in place of at 33%/19% respectively to reset levels to ensure UCITS compliance at all times.

The Index of Chimera S&P Pakistan UCITS ETF is a modified weighted total return index measuring the performance of the top 15 Pakistan domiciled companies ranked in the S&P Pakistan BMI Index. The S&P Pakistan BMI Index is a leading benchmark for tracking performance of Pakistani companies. The Index is comprised of the top 15 constituents of the S&P Pakistan BMI Index that meet the following eligibility requirements: (i) companies must have no more than ten non-trading days over the previous quarter; and (ii) have a six-month average daily value traded of at least US$200,000 for at least one of the two quarterly periods preceding the rebalancing reference date.

The Index follows a six-month average daily traded value of >= $200,000. Stocks failing to meet this level will drop out of the Index once this liquidity screen fails to be met for the six-month period preceding the rebalancing reference date.

The Index of Chimera JP Morgan UAE Bond UCITS ETF is a subset of the J.P. Morgan Middle East Composite Index (MECI) (the "Parent Index"). The Index comprises the UAE investment grade USD-denominated corporate, quasi-sovereign and sovereign bond issues. The Parent Index is a leading index tracking the performance of USD-denominated debt in the Middle East. The index constituents must have a minimum face value outstanding of US$500 million, an outstanding maturity between one and two and a half years and bond ratings of BBB- or higher by at least two out of three ratings agencies of Standard & Poor's, Moody's and Fitch.

Page 18

Chimera UCITS ICAVCondensed Interim Report & Unaudited Financial StatementsFor the financial period from 1 January 2024 to 30 June 2024Notes to the Unaudited Financial Statements (continued)15

1. Organisation (continued)

Index rebalancing occurs monthly on the last business day of each month. The Index applies a dual capping methodology, where all issuers are initially capped at 9.0%. The Index is then recalculated until all issuers are below the cap. The issuers above 4.5% are ranked, and the aggregate of these issuers must be below the 38.0% threshold, the highest ranked issuer that breaches the threshold and all remaining issuers in the index are capped at 4.5% after reweighting is applied. These reset triggers of 4.5%/9.0%/38.0% have been set by the Index Provider, JP Morgan, to ensure compliance with the UCITS diversification rules (ie.

the 5/10/40 Rule) by creating a buffer below the regulatory limits.

The Index of Chimera S&P Japan UCITS ETF is modified weighted total return index measuring the performance of the top 30

Japan domiciled companies ranked in the S&P Japan BMI Index. The constituents of the S&P Japan BMI Index that meet the following eligibility requirements: (i) companies must have no more than ten non-trading days over the previous quarter; and (ii) have a six-month average daily value traded of at least US$1,000,000 for at least one of the two quarterly periods preceding the rebalancing reference date.

The Index applies a UCITS capping screen of 35%/20%. This is to allow the Fund, whose policy is to replicate the Index, to invest up to 20% of its net assets in individual securities with the 20% limit being raised up to 35% in the case of a single issuer where justified by exceptional market conditions which may include the dominance of a particular issuer in the relevant market. The Index provider, S&P, has set triggers in place at 33%/19% respectively to reset levels to ensure UCITS compliance at all times.

In order to achieve its investment objective, the investment policy of the Sub-Funds are to invest 100% of their net assets in a portfolio of equity and bond securities that consists of the equity and bond securities of each Index. Lunate Capital Limited (the "Investment Manager"), may deviate from the 100% investment where it is, for whatever reason, not possible to buy and hold a particular Index security.

The Sub-Funds attempt to replicate, before fees and expenses, the performance of each Index. The Investment Manager will seek to do this by replicating so far as possible the investments in each Index by holding all of the securities comprising each Index in approximately the same proportion as its weighting in each Index.

The base currency of Chimera S&P UAE UCITS ETF (the “Sub-Fund”), Chimera S&P Pakistan UCITS ETF (the “Sub- Fund"), Chimera JP Morgan UAE Bond UCITS ETF (the "Sub-Fund) and Chimera S&P Japan UCITS ETF (the "Sub-Fund") is the United Arab Emirates Dirham (“AED”), Pakistani Rupee ("PKR"), U.S. Dollar ("USD") and Japanese Yen ("JPY") respectively. The base currency of the ICAV is AED. The Net Asset Value per Share will be published and settlement and dealing will be affected in the designated currency of each Class.

The shares of the active Sub-Funds are listed and admitted for trading on the following stock exchanges: Class A Accumulating Shares are listed on the Dubai Financial Market while Class D Distributing Shares are listed on Abu Dhabi Securities Exchange.

2. Material Accounting Policies

(a) Basis of preparation

These condensed interim report and unaudited financial statements have been prepared in accordance with IAS 34, "Interim Financial Reporting", the ICAV Act, the UCITS Regulations and the Central Bank UCITS Regulations and should be read in conjunction with the annual report and audited financial statements for the financial year ended 31 December 2023.

Selected explanatory notes are included to explain events and transactions that are significant to an understanding of the changes in the financial position and performance of the Sub-Fund since the last annual report and audited financial statements.

They do not include all the information required for a full set of annual financial statements prepared in accordance with International Financial Reporting Standards ("IFRS").

The condensed interim report and unaudited financial statements have been prepared on a going concern basis which assumes that the ICAV will continue in operational existence for the foreseeable future and have been prepared under the historical cost convention, as modified by the revaluation of financial assets and financial liabilities at fair value through profit or loss.

Page 19

Chimera UCITS ICAV

Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2024 to 30 June 2024 Notes to the Unaudited Financial Statements (continued) 16

2. Material Accounting Policies (continued)

(a) Basis of preparation (continued)

The preparation of the condensed interim report and unaudited financial statements in conformity with IFRS requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities at the reporting date and the reported amounts of revenues and expenses during the reporting period. Although these estimates are based on management’s best knowledge of the amount, event or actions, actual results ultimately may differ from those estimates.

The Directors make estimates and assumptions concerning the future of the ICAV. The resulting accounting estimates will, by definition, seldom equal the related actual results. There are no estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities.

International Financial Reporting Standards

New accounting standards, amendments and interpretations in issue and effective for the financial periods beginning on or after 1

January 2024

At the date of approval of these financial statements, the following standards, amendments and interpretations to existing standards were adopted by the ICAV effective from 1 January 2024:

Amendments to IAS 1 Classification of Liabilities as Current or Non-Current

On 23 January 2020, the IASB issued 'Classification of Liabilities as Current or Non-current (Amendments to IAS 1)' providing a more general approach to the classification of liabilities under IAS 1 based on the contractual arrangements in place at the reporting date. The amendments were originally effective for annual reporting periods beginning on or after 1 January 2023, however, their effective date has been delayed to 1 January 2024.

The adoption of Amendments to IAS 1 Classification of Liabilities as Current or Non-Current did not have a significant impact on the ICAV’s financial statements.

IFRS 17 Insurance Contracts

This standard replaces IFRS 4, which permits a wide variety of practices in accounting for insurance contracts. IFRS 17 will fundamentally change the accounting by all entities that issue insurance contracts and investment contracts with discretionary participation features.

The amendments are effective for annual reporting periods beginning on or after 1 January 2024 with earlier application permitted.

The adoption of IFRS 17, ‘Insurance Contracts’ did not have a significant impact on the ICAV’s financial statements.

Amendments to IAS 1 and IFRS Practice Statement 2 Disclosure of Accounting Policies

The IASB issued 'Disclosure of Accounting Policies (Amendments to IAS 1 and IFRS Practice Statement 2)' with amendments that are intended to help preparers in deciding which accounting policies to disclose in their financial statements. The amendments aim to improve accounting policy disclosures.

The amendments are effective for annual reporting periods beginning on or after 1 January 2024 with earlier application permitted.

The adoption of Amendments to IAS 1 and IFRS Practice Statement 2 Disclosure of Accounting Policies did not have a significant impact on the ICAV’s financial statements.

IFRS S1 - General Requirements for disclosure of sustainability-related financial information

This standard includes the core framework for the disclosure of material information about sustainability-related risks and opportunities across an entity's value chain.

Page 20

Chimera UCITS ICAV

Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2024 to 30 June 2024 Notes to the Unaudited Financial Statements (continued) 17

2. Material Accounting Policies (continued)

(a) Basis of preparation (continued)

IFRS S2 - Climate-related disclosures

This is the first thematic standard issued that sets out requirements for entities to disclose information about climate-related risks and opportunities.

Standards, interpretations and amendments to existing standards in issue but not yet effective and not early adopted At the date of approval of these financial statements, the ICAV has not applied the following new and revised IFRS Standards that have been issued but are not yet effective:

New and revised IFRSEffective for annual periodsbeginningon or afterAmendment to IAS 21 Lack of Exchangeability 1 January 2025

Amendments to IFRS 10 Consolidated Financial Statements and IAS 28 Investments in Associates and Joint Ventures (2011) relating to the treatment of the sale or contribution of assets from and investor to its associate or joint venture.

1 January 2025

The ICAV is currently evaluating the impact, if any, that these new and revised IFRS Standards will have on its financial statements.

The Manager anticipates that these IFRSs and amendments will be adopted in the financial statements in the initial period when they become mandatorily effective. The Manager assessed that adoption of these amendments will not have a significant impact on the ICAV’s financial statements.

There are no other standards, interpretations and amendments to existing standards in issue but not yet effective that would be expected to have a significant impact on the ICAV.

(b) Material Accounting Polices

The material accounting policies and estimation techniques adopted by the ICAV for the financial period ended 30 June 2024 are consistent with those adopted by the ICAV for the annual report and audited financial statements for the financial year ended 31

December 2023.

3. Fair Value

IFRS 13 ‘Fair Value Measurement’ requires disclosure relating to the fair value hierarchy in which fair value measurements are categorised as assets and liabilities in the Statement of Financial Position.

The disclosures are based on a three-level fair value hierarchy for the inputs used in valuation techniques to measure fair value.

The fair value of financial assets and financial liabilities traded in an active market (such as trading securities) are based on quoted market prices at the close of trading on the reporting date.

A financial instrument is regarded as quoted in an active market if the quoted prices are readily and regularly available from an exchange, dealer, broker, industry group, pricing service, or regulatory agency, and those prices represent actual and regularly occurring market transactions on an arm's length basis. These instruments are included within Level 1 of the hierarchy.

The fair value of financial assets and financial liabilities that are not traded in an active market is determined by using valuation techniques. The ICAV uses a variety of methods and makes assumptions that are based on market conditions existing at the reporting date. These instruments are included within Level 2 of the hierarchy. The fair value hierarchy has the following levels:

• Quoted prices (unadjusted) in active markets for identical assets or liabilities (Level 1).

• Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly (that is, as prices) or indirectly (that is, derived from prices) (Level 2).

Page 21

Chimera UCITS ICAV

Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2024 to 30 June 2024 Notes to the Unaudited Financial Statements (continued) 18

3. Fair Value (continued)

Inputs for the asset or liability that are not based on observable market data (that is, unobservable inputs) (Level 3).

Transfers are deemed to occur at the end of the financial period.

There were no transfers between levels during the financial period ended 30 June 2024 and the financial year ended 31 December 2023 for the Sub-Fund.

The tables overleaf provide an analysis of financial instruments at 30 June 2024 and 31 December 2023 that are measured at fair value in accordance with IFRS 13:

Chimera S&P UAE UCITS ETF

Financial Assets at Fair Value through Profit or Loss As at 30 June 2024

Level 1 Level 2 Level 3 Total

AEDAEDAEDAED

Transferable securities

Equities118,445,857––118,445,857

Total118,445,857––118,445,857

Chimera S&P UAE UCITS ETF

Financial Assets at Fair Value through Profit or Loss As at 31 December 2023

Level 1 Level 2 Level 3 Total

AEDAEDAEDAED

Transferable securities

Equities125,540,893––125,540,893

Total125,540,893––125,540,893

Chimera S&P Pakistan UCITS ETF

Financial Assets at Fair Value through Profit or Loss As at 30 June 2024

Level 1 Level 2 Level 3 Total

PKRPKRPKRPKR

Transferable securities

Equities435,828,711––435,828,711

Total435,828,711––435,828,711

Page 22

Chimera UCITS ICAV

Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2024 to 30 June 2024 Notes to the Unaudited Financial Statements (continued) 19

3. Fair Value (continued)

Chimera S&P Pakistan UCITS ETF*

Financial Assets at Fair Value through Profit or Loss As at 31 December 2023

Level 1 Level 2 Level 3 Total

PKRPKRPKRPKR

Transferable securities

Equities364,655,675––364,655,675

Total364,655,675––364,655,675

* Chimera S&P Pakistan UCITS ETF was launched on 17 August 2023.

Chimera JP Morgan UAE Bond UCITS ETF**

Financial Assets at Fair Value through Profit or Loss As at 30 June 2024

Level 1 Level 2 Level 3 Total

USDUSDUSDUSD

Transferable securities

Corporate Bonds–5,005,937–5,005,937

Government Bonds–904,194–904,194

Total–5,910,131–5,910,131

**Chimera JP Morgan UAE Bond UCITS ETF was launched on 25 March 2024. Therefore, there are no comparatives as at the financial year ended 31 December 2023.

Chimera S&P Japan UCITS ETF***

Financial Assets at Fair Value through Profit or Loss As at 30 June 2024

Level 1 Level 2 Level 3 Total

JPYJPYJPYJPY

Transferable securities

Equities876,166,465––876,166,465

Total876,166,465––876,166,465

***Chimera S&P Japan UCITS ETF was launched on 28 May 2024. Therefore, there are no comparatives as at the financial year ended 31 December 2023.

Assets and liabilities not carried at fair value but for which fair value is disclosed

The ICAV’s assets and liabilities (by class) not measured at fair value at 30 June 2024 and 31 December 2023 but for which fair value is disclosed within the fair value hierarchy are considered Level 2, except for cash and cash equivalents, which are considered Level 1.

Cash and cash equivalents include cash on hand and demand deposits held with banks and brokers.

Page 23

Chimera UCITS ICAVCondensed Interim Report & Unaudited Financial StatementsFor the financial period from 1 January 2024 to 30 June 2024Notes to the Unaudited Financial Statements (continued)20

4. Share Capital

The issued share capital of the ICAV shall be not less than the currency equivalent of €2 represented by two subscriber shares of no par value and the maximum issued share capital of the ICAV shall not be more than 500 billion shares of no par value. The share capital of the ICAV shall at all times equal the Net Asset Value of the ICAV.

The subscriber shares entitle the holders to attend and vote at all meetings of the ICAV but do not entitle the holders to participate in the dividends or net assets of any Sub-Fund or of the ICAV. The holders of the subscriber shares shall have one vote for each subscriber share held.

Each of the redeemable shares entitles the Shareholder to participate equally on a pro rata basis in the dividends and net assets of a Sub-Fund attributable to the relevant Class in respect of which they are issued, save in the case of dividends declared prior to becoming a Shareholder.

The Directors reserve the right to predesignate any class of shares from time to time, provided that Shareholders in that class shall first have been notified by the ICAV thirty calendar days in advance that the shares will be predesignated and shall have been given the opportunity to have their shares redeemed by the ICAV, except that this requirement shall not apply where the Directors predesignate shares in issue in order to facilitate the creation of an additional class of shares.

Each of the redeemable shares entitles the holder to attend and vote at meetings of the ICAV and of the relevant Sub-Fund represented by those shares. No class of shares confers on the holder thereof any preferential or pre-emptive rights or any rights to participate in the profits and dividends of any other class of shares or any voting rights in relation to matters relating solely to any other class of shares.

Any resolution to alter the class rights of the shares requires the approval of three quarters of the holders of the shares represented or present and voting at a general meeting duly convened in accordance with the Instrument of Incorporation.

The following table shows the share class movement during the financial period ended 30 June 2024 and financial year ended 31

December 2023:Chimera S&P UAE UCITS ETFFinancial Period1 January 2024to 30 June 2024Financial YearEnded31 December 2023Class A Accumulating Shares

Balance at beginning of financial period/year500,000500,000

Shares issued––

Shares redeemed––

Balance at end of financial period/year500,000500,000

Class D Distributing Shares

Balance at beginning of financial period/year28,000,00029,000,000

Shares issued––

Shares redeemed^–(1,000,000)

Balance at end of financial period/year28,000,00028,000,000

^ Includes prior year in-kind redemptions of 1,000,000 shares valued at AED 4,571,000 for Class D Distributing Shares.

Page 24

Chimera UCITS ICAV

Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2024 to 30 June 2024 Notes to the Unaudited Financial Statements (continued) 21

4. Share Capital (continued)

Chimera S&P Pakistan UCITS ETF*Financial Period1 January 2024to 30 June 2024Financial YearEnded31 December 2023Class D Distributing Shares

Balance at beginning of financial period/year1,000,000–

Shares issued–1,000,000

Shares redeemed––

Balance at end of financial period/year1,000,0001,000,000

*Chimera S&P Pakistan UCITS ETF was launched on 17 August 2023.

Chimera JP Morgan UAE Bond UCITS ETF** Financial Period from

25 March 2024to 30 June 2024

Class D Income Distributing Shares Balance at beginning of financial period – Shares issued 6,500,000

Shares redeemed (500,000)Balance at end of financial period 6,000,000

**Chimera JP Morgan UAE Bond UCITS ETF was launched on 25 March 2024. Therefore, there are no comparatives as at the financial year ended 31 December 2023.

Chimera S&P Japan UCITS ETF***Financial Period from28 May 2024to 30 June 2024Class D Distributing Shares

Balance at beginning of financial period – Shares issued^ 6,000,000

Shares redeemed^ (500,000)Balance at end of financial period 5,500,000

***Chimera S&P Japan UCITS ETF was launched on 28 May 2024. Therefore, there are no comparatives as at the financial year ended 31 December 2023.

^Include in-kind subscriptions of 6,000,000 shares valued at JPY 942,000,000 for Class D Distributing Shares and in-kind redemptions of 500,000 shares valued at JPY 79,337,500 for Class D Distributing Shares.

Page 25

Chimera UCITS ICAV

Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2024 to 30 June 2024 Notes to the Unaudited Financial Statements (continued) 22

5. Net Losses on Financial Assets at Fair Value Through Profit or Loss Chimera S&P UAE

UCITS ETFChimera S&P PakistanUCITS ETF*Financial Period1 January 2024to 30 June 2024Financial Period1 January 2023to 30 June 2023Financial Period1 January 2024to 30 June 2024AED AED PKRNet realised (losses)/gains on sale of

financial assets at FVTPL(920,663)(717,891)13,005,596

Net realised gains/(losses) on other currency224–(241)

Net change in unrealised(depreciation)/appreciation on financial

assets at FVTPL(8,172,638)(3,604,343)71,079,380

Other currency losses––(6)

Net (losses)/gains on financial assets at

fair value through profit or loss(9,093,077)(4,322,234)84,084,729

*Chimera S&P Pakistan UCITS ETF was launched on 17 August 2023. Therefore, there are no comparatives as at the financial period ended 30 June 2023.

Chimera JP Morgan UAE BondUCITS ETF**Chimera S&P JapanUCITS ETF***Financial Period from25 March 2024to 30 June 2024Financial Period from28 May 2024to 30 June 2024USD JPYNet realised (losses)/gains on sale of

financial assets at FVTPL(23,631)389,816

Net change in unrealised(depreciation)/appreciation on financial

assets at FVTPL(41,559)16,364,571

Other currency losses(1)–

Net (losses)/gains on financial assets at

fair value through profit or loss(65,191)16,754,387

**Chimera JP Morgan UAE Bond UCITS ETF was launched on 25 March 2024. Therefore, there are no comparatives as at the financial period ended 30 June 2023.

***Chimera S&P Japan UCITS ETF was launched on 28 May 2024. Therefore, there are no comparatives as at the financial period ended 30 June 2023.

6. Cash and Cash Equivalents

Cash and cash equivalents held at the financial period ended 30 June 2024 and the financial year ended 31 December 2023 are held with The Bank of New York Mellon SA/NV, Dublin Branch (the "Depositary").

The Standard & Poor’s long term credit rating of the Depositary was AA- at 30 June 2024 and 31 December 2023.

Page 26

Chimera UCITS ICAVCondensed Interim Report & Unaudited Financial StatementsFor the financial period from 1 January 2024 to 30 June 2024Notes to the Unaudited Financial Statements (continued)23

7. Taxation

Under current law and practice, the ICAV qualifies as an investment undertaking as defined in Section 739B of the Taxes Consolidation Act, 1997, as amended. On that basis, it is not chargeable to Irish tax on its income or gains.

However, Irish tax may arise on the happening of a "chargeable event". A chargeable event includes any distribution payments to Shareholders, any encashment, redemption, cancellation or transfer of Shares and the holding of Shares at the end of each eight year period beginning with the acquisition of such Shares.

No Irish tax will arise on the Sub-Fund in respect of chargeable events in respect of:

(a) transactions by a Shareholder who is neither Irish resident nor ordinarily resident in Ireland for tax purposes at the time of the chargeable event, provided the appropriate valid declarations, in accordance with the provisions of the Taxes Consolidation Act, 1997, as amended, are held by the Sub-Fund or the Sub-Fund has been authorised by the Irish Revenue to make gross payments in the absence of appropriate declarations; and

(b) transactions by certain exempted Irish resident Shareholders who have provided the Sub-Fund with the necessary signed statutory declarations.

Dividends, interest and capital gains, (if any), received on investments made by the Sub-Fund may be subject to taxes imposed by the country from which the investment income/gains are received, and such taxes may not be recoverable by the Sub-Fund or its Shareholders.

8. Expenses

The ICAV shall pay to the Manager out of the Sub-Fund’s assets an annual Management Fee of 1% of the Sub-Fund’s daily Net Asset Value. The Manager will retain a fee for its remuneration (in respect of the provision of management services and such other services as have been agreed with the Manager, including the provision of company secretarial services, MLRO services and the maintenance of the ICAV’s beneficial ownership register) out of the Management Fee and any reasonable and properly vouched expenses as well as extraordinary expenses outside the ordinary course of business where agreed in advance with the ICAV and shall further discharge all fees and expenses related to the Sub-Fund.

The following expenses will be discharged by the Manager out of the Management Fee: fees payable to the Depositary, Administrator, Investment Manager, Global Distributor and Directors and all operational expenses, including but not limited to, expenses and reasonable out of pocket expenses of the Depositary, Administrator, Investment Manager, Global Distributor and Directors, the costs of maintaining the Sub-Funds and any registration of the Funds with any governmental or regulatory authority; the costs of registering a Fund in other jurisdictions or with any stock exchange, filing fees; preparation, printing, and posting of the Prospectus and other prospectuses, sales literature and reports to shareholders, regulatory fees of the CBI and other governmental agencies; insurance premiums; fees and expenses for legal, audit, other professionals and other services; levies incurred in connection with acquiring or disposing of Investments or in connection with creation and redemption transactions including any fees and expenses payable as a result of entering into FDI transactions or arising from investment in collective investment schemes (including, without limitation, any fees, charges, taxes, levies or expenses related to the purchase or sale of an amount of any currency, or the patriation or repatriation of any security or other asset, or related to the execution of portfolio transactions or any creation or redemption transactions); fees and expenses incurred in connection with securities lending; paying for sublicensing fees related to each Fund's Index and any distribution fees or expenses but excluding interest, taxes, brokerage commissions and other expenses connected with execution of portfolio transactions, and extraordinary expenses. Where the above expenses exceed the Management Fees, the Investment Manager will discharge any such expenses out of its own assets.

The fees and expenses relating to the establishment and approval of the Sub-Fund, including the fees of the ICAV’s professional advisers, the fees and expenses incurred with respect to registering the shares of the Sub-Fund for sale in various markets, and the expenses associated with the issue of shares, including the costs incurred in connection with the preparation and publication of the Supplement, and all legal and printing costs will be borne by the Investment Manager.

Page 27

Chimera UCITS ICAVCondensed Interim Report & Unaudited Financial StatementsFor the financial period from 1 January 2024 to 30 June 2024Notes to the Unaudited Financial Statements (continued)24

9. Transaction Costs

Transaction costs are incremental costs that are directly attributable to the acquisition, issue or disposal of a financial asset or financial liability. An incremental cost is one that would not have been incurred if the entity had not acquired, issued or disposed of the financial instrument. When a financial asset or financial liability is recognised initially, an entity shall measure it at its fair value through profit or loss plus, transaction costs that are directly attributable to the acquisition or issue of the financial asset or financial liability.

Transaction costs on purchases and sales of equities are borne by the Sub-Fund and included within net gains/(losses) on investments in the Statement of Comprehensive Income. Purchases and sales transaction costs include identifiable brokerage charges, commissions, transaction related taxes and other market charges.

Transactions costs incurred on purchases and sales during the financial period ended 30 June 2024 and 30 June 2023 were as follows.

Sub-Fund Base Currency Financial period ended30 June 2024Financial period ended30 June 2023Chimera S&P UAE UCITS ETF AED 16,626 19,447

Chimera S&P Pakistan UCITS ETF* PKR 252,803 Nil Chimera JP Morgan UAE Bond UCITS ETF** USD Nil Nil

Chimera S&P Japan UCITS ETF*** JPY 49,805 Nil

*Chimera S&P Pakistan UCITS ETF was launched on 17 August 2023. Therefore, there are no comparatives as at the financial period ended 30 June 2023.

**Chimera JP Morgan UAE Bond UCITS ETF was launched on 25 March 2024. Therefore, there are no comparatives as at the financial year ended 30 June 2023.

***Chimera S&P Japan UCITS ETF was launched on 28 May 2024. Therefore, there are no comparatives as at the financial year ended 30 June 2023.

10. Related Parties transactions

According to IAS 24 Related Parties, parties are considered to be related if one party has the ability to control the other party or exercise significant influence over the other party in making financial or operational decisions or is a member of the key management personnel of the reporting entity or of a parent of the reporting entity. The following related party relationships and transactions have been identified. The Directors, the Manager and the Investment Manager are considered as key management personnel for this purpose.

The Manager is entitled to receive out of the Sub-Fund’s assets an annual Management Fee of 1% of the Sub-Fund’s daily Net Asset Value. The Manager will retain a fee for its remuneration (in respect of the provision of management services and such other services as have been agreed with the Manager, including the provision of company secretarial services, MLRO services and the maintenance of the ICAV’s beneficial ownership register). The Manager is also entitled to be reimbursed for any reasonable and properly vouched expenses (the “Manager’s Expenses”) as well as extraordinary expenses outside the ordinary course of business where agreed in advance with the ICAV.

Total fees earned by the Manager during the financial period ended 30 June 2024 amounted to EUR 28,333 (30 June 2023: EUR 15,000), of which EUR 10,000 was outstanding at 30 June 2024 (31 December 2023: EUR 4,167).

The emoluments of all the Directors who are entitled to remuneration for their services as Directors in respect of any twelve-month accounting period shall not exceed €80,000 or such higher amount as may be approved by the Board of Directors. The Directors are also entitled to be reimbursed for their reasonable out of pocket expenses incurred in discharging their duties as Directors.

Such fees and expenses are paid out of the Annual Management fee paid to the Manager.

Page 28

Chimera UCITS ICAVCondensed Interim Report & Unaudited Financial StatementsFor the financial period from 1 January 2024 to 30 June 2024Notes to the Unaudited Financial Statements (continued)25

10. Related Parties transactions (continued)

Directors’ fees incurred during the financial period ended 30 June 2024 amounted to EUR 20,000 (30 June 2023: EUR 20,000), of which EUR Nil was outstanding at 30 June 2024 (31 December 2023: EUR Nil). Directors' fees were earned by 2 of the Independent Directors. None of the Directors who are employees of the Investment Manager or its related entity earned fees during the financial period ended 30 June 2024 and 30 June 2023.

The Investment Manager earned fees for investment management services of AED 689,880 during the financial period ended 30

June 2024 (30 June 2023: AED 631,606), of which AED 379,388 was outstanding at 30 June 2024 (31 December 2023: AED 326,751). As with the other expenses, the fees are paid out of the Annual Management fee paid to the Manager.

At 30 June 2024, the ICAV had four Authorised Participants Arqaam Capital, BHM Capital Financial Services PrJSC, EFG Hermes UAE LLC and International Securities L.L.C, through which share transactions are conducted on the primary market.

International Securities L.L.C is a related party to the ICAV and the Investment Manager.

At 30 June 2024, 2 Subscriber Shares were held on behalf of the ICAV by the Investment Manager.

11. Contingent Liabilities and Commitments

There were no contingent liabilities or commitments as at the period ended 30 June 2024 and the year ended 31 December 2023.

12. Segregation of Liability

The ICAV is an umbrella fund with segregated liability between Sub-Funds and each Sub-Fund may comprise one or more classes of shares in the ICAV. The Directors may, from time to time, upon the prior approval of the CBI, establish further Sub-Funds by the issue of one or more separate classes of shares on such terms as the Directors may resolve. The Directors may, from time to time, in accordance with the requirements of the CBI, establish one or more separate classes of shares within each Sub-Fund on such terms as the Directors may resolve.

13. Umbrella Cash Collection Accounts

The CBI published the Central Bank (Supervision and Enforcement) Act 2013 (Section 48(1)) Investor Money Regulations 2015 for Fund Service Providers (the “Investor Money Regulations” or “IMR”) in March 2015 (effective from 1 July 2016). The Manager, together with the Administrator implemented procedures in relation to the way subscription and redemption monies are channeled to and from the ICAV. These transactions are channeled through an umbrella cash collection account in the name of the ICAV. Pending issue of the shares and/or payment of subscription proceeds to an account in the name of the ICAV or the relevant Sub-Funds, and pending payment of redemption proceeds or distributions, the relevant investor will be an unsecured creditor of the relevant Sub-Fund in respect of amounts paid by or due to it. As at 30 June 2024 and 31 December 2023, there was no IMR related balance included within cash and cash equivalents in the Statement of Financial Position.

14. Net Asset Value Attributable to Holders of Redeemable Participating Shares

Chimera S&P UAE UCITS ETFAs at30 June 2024As at31 December 2023As at31 December 2022Total Net Asset ValueClass A Accumulating Shares AED2,323,039 AED2,406,435 AED2,359,267

Class D Distributing Shares AED116,266,041 AED123,343,017 AED129,074,655

Net Asset Value per Share

Class A Accumulating Shares AED4.646 AED4.813 AED4.719 Class D Distributing Shares AED4.152 AED4.405 AED4.451

Page 29

Chimera UCITS ICAV

Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2024 to 30 June 2024 Notes to the Unaudited Financial Statements (continued) 26

14. Net Asset Value Attributable to Holders of Redeemable Participating Shares (continued) Chimera S&P Pakistan UCITS ETF*

As at30 June 2024As at31 December 2023Total Net Asset Value

Class D Distributing Shares PKR467,052,762 PKR366,562,034 Net Asset Value per Share

Class D Distributing Shares PKR467.053 PKR366.562

*Chimera S&P Pakistan UCITS ETF was launched on 17 August 2023. Therefore, there are no comparatives as at the financial year ended 31 December 2022.

Chimera JP Morgan UAE Bond UCITS ETF**As at30 June 2024Total Net Asset ValueClass D Distributing Shares USD6,009,212Net Asset Value per ShareClass D Distributing Shares USD1.002

**Chimera JP Morgan UAE Bond UCITS ETF was launched on 25 March 2024. Therefore, there are no comparatives as at the financial years ended 31 December 2023 and 31 December 2022.

Chimera S&P Japan UCITS ETF***As at30 June 2024Total Net Asset Value

Class D Distributing Shares JPY878,654,739 Net Asset Value per Share

Class D Distributing Shares JPY159.755

***Chimera S&P Japan UCITS ETF was launched on 28 May 2024. Therefore, there are no comparatives as at the financial years ended 31 December 2023 and 31 December 2022.

15. Soft Commissions and Directed Brokerage Arrangements

There were no soft commissions and directed brokerage arrangements entered into by the ICAV and the Sub-Fund during the financial periods ended 30 June 2024 and 30 June 2023.

Page 30

Chimera UCITS ICAV

Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2024 to 30 June 2024 Notes to the Unaudited Financial Statements (continued) 27

16. Distributions

Distributions from Chimera S&P UAE UCITS ETF per share class during the financial periods ended 30 June 2024 and 30 June 2023 were as follows:

Financial period ended 30 June 2024 Dividend per

Share Class Ex Date Pay DateRedeemable ParticipatingShareAmountAED

Class D Distributing Shares 14 June 2024 10 July20240.09762,732,800

Financial period ended 30 June 2023 Dividend per

Share Class Ex Date Pay DateRedeemable ParticipatingShareAmountAED

Class D Distributing Shares 14 June 2023 10 July20230.05911,713,900

17. Exchange Rates

The following average exchange rate was used to convert certain expense payments to AED:

Financial period ended30 June 2024Financial year ended31 December 2023Financial period ended30 June 2023

EUR0.2517750.2518780.252061

JPY 41.365912N/AN/A

PKR 75.966613 76.198719 N/A

USD 0.272269N/AN/A

18. Efficient Portfolio Management

The Investment Manager may, on behalf of the Sub-Fund and subject to the conditions and within the limits laid down by the CBI, employ techniques and instruments relating to transferable securities and money market instruments for efficient portfolio management purposes in accordance with the investment strategy of the Sub-Fund.

Transactions for the purposes of efficient portfolio management may be undertaken with a view to achieving the reduction of risk, the reduction of cost, or the generation of additional capital or income for the Sub-Fund with an appropriate level of risk and taking into account the risk profile of that Sub-Fund. Techniques and instruments used for efficient portfolio management purposes may include investments in financial derivative instruments (“FDI”) including futures, options and swaps, the entry into securities lending transactions, repurchase and/or reverse repurchase agreements. All revenues arising from efficient portfolio management activities, net of direct and indirect operational costs will be retained by the Sub-Fund and recognised in the Statement of Comprehensive Income.

The Sub-Fund did not engage in any efficient portfolio management activities during the financial periods ended 30 June 2024 and 30 June 2023.

19. Transactions with Connected Persons

Regulation 43 (1) of the Central Bank UCITS Regulations “Restrictions of transactions with connected persons” states that “A responsible person shall ensure that any transaction between a UCITS and a connected person is conducted a) at arm’s length; and b) in the best interest of the shareholders of the UCITS”.

As required under the Central Bank UCITS Regulation 81 (4), the Manager, as responsible person, has confirmed to the Board of Directors of the ICAV that it is satisfied that there are arrangements in place, evidenced by written procedures, to ensure that obligations set out in Regulation 43(1) are applied to all transactions with connected persons; and all transactions with connected persons that were entered into during the financial period to which the report relates, complied with the obligations that are prescribed by Regulation 43(1).

Show all 47 pages